Description
Erlotinib is a quinazoline derivative with antineoplastic properties. … It has a role as an antineoplastic agent, a protein kinase inhibitor and an epidermal growth factor receptor antagonist. It is a member of quinazolines, a terminal acetylenic compound, an aromatic ether and a secondary amino compound.
Additional information
Generic | |
---|---|
CAS No | 183319-69-9 |